N

NewLimit

Develops epigenetic medicines to extend healthspan

Director of Clinical Operations

Clinical Research OperationsConfirmed live in the last 24 hours
Full-timeSouth San Francisco, CA, USANo salary listedRemote

About the Job

Requirements

  • At least 10 years of industry experience in Clinical Operations and a Bachelor's or advanced degree in the life sciences.
  • A history of orchestrating clinical trials through contract research organization partners with accountability for operational delivery.
  • Recent experience managing first-in-human trials.
  • Experience managing trials across multiple geographies, including the United States, Australia, New Zealand, the European Union, the United Kingdom, and Japan.
  • A quantitative mindset, including tracking metrics, reporting numbers rather than anecdotes, and driving measurable improvements quarter over quarter.
  • Experience managing clinical trial budgets, forecasts, and resource planning.

Responsibilities

  • Lead clinical trial execution through protocol development, contract research organization selection and management, and startup activities across the United States, Australia/New Zealand, the European Union, and the United Kingdom.
  • Collaborate with clinical development to ensure trial designs and execution provide maximum benefit to patients and maximum information per dollar.
  • Manage and own company-wide clinical trial timelines and budgets, and construct and instrument clinical operations metrics.
  • Resolve operational challenges in trial execution, including recruitment, cross-border logistics, regulatory compliance, and staffing.
  • Build and manage a high-performing clinical operations team as its founding member.
  • Support regulatory submissions and ongoing global compliance obligations.

Desired Qualifications

  • Recent experience coordinating first-in-human trials in Australia and New Zealand.
  • Experience managing trials in metabolic disease and hepatology.
  • Experience recruiting a clinical operations team on a short time horizon.
  • A history of developing nucleic acid medicines, including mRNA, ASO, and siRNA, and lipid nanoparticle-vectored products.

About the Company

NewLimit

Develops epigenetic medicines to extend healthspan

NewLimit develops medicines that aim to extend healthy years by reprogramming the epigenome of aging cells. It works by identifying aging-related epigenetic changes using single-cell genomics, machine learning, and high-throughput functional assays, then creating interventions to reverse those changes in targeted tissues such as the immune system and liver. Compared with others, NewLimit combines a specific focus on epigenetic reprogramming with a data-driven, tissue-targeted pipeline and pursues partnerships with pharma and biotech players to develop its proprietary medicines. Its goal is to deliver a new class of medicines that significantly increases the healthspan for patients with age-related diseases.

Company size
51-200
Company stage
Series C
Total funding
$650M
Headquarters
South San Francisco, CA
Founded
2022

Recently Posted Jobs

Explore more opportunities at NewLimit

See more jobs